News & Updates
Showing Infectious Diseases articles
Showing
Better CV health tied to lower severe COVID-19 risk in adults without CVD
In the C4R* consortium, better cardiovascular health (CVH)—as quantified by the AHA’s** Life’s Essential 8 (LE8)—is associated with a lower risk of severe COVID-19 (ie, hospitalization or death) in individuals without clinical cardiovascular disease (CVD).
Better CV health tied to lower severe COVID-19 risk in adults without CVD
25 Jun 2026
Nirsevimab prevents RSV-related hospitalizations, severe disease in infants
Treatment with nirsevimab has been shown to bring down the number of hospitalizations due to respiratory syncytial virus (RSV) infections and prevent the development of severe disease in infants, according to a study presented at ESPID 2026.
Nirsevimab prevents RSV-related hospitalizations, severe disease in infants
24 Jun 2026
Direct-acting antivirals improve survival in patients with HCV-related HCC
A recent study in UK has shown a significant proportion of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) initiating direct-acting antiviral (DAA) therapy, resulting in improvements in sustained virological response (SVR) rates.
Direct-acting antivirals improve survival in patients with HCV-related HCC
22 Jun 2026
Fluvoxamine wins, metformin disappoints in long COVID fatigue
The antidepressant fluvoxamine reduces long COVID fatigue, whereas the antidiabetic agent metformin fails to outperform placebo in the randomized REVIVE-TOGETHER trial.
